Fig. 3: CT55 deficiency inhibits the tumorigenic features of colorectal cancer cells. | Cell Death & Disease

Fig. 3: CT55 deficiency inhibits the tumorigenic features of colorectal cancer cells.

From: Cancer testis antigen 55 deficiency attenuates colitis-associated colorectal cancer by inhibiting NF-κB signaling

Fig. 3

a CCK8 assays were performed to evaluate the cell viability of HCT116 CT55 KO cells compared with the WT control (n = 6, **P < 0.01). b Relative colony formation units of HCT116 WT and HCT116 CT55 KO cells (left). The quantification of the indicated relative colony-forming units (n = 3, *P < 0.05) (right). c The tumor volumes of the HCT116 and HCT116 CT55 KO-treated mice 25 days after transplantation. d Representative images of the injected mice (n = 5, **P < 0.01). e Tumor weights and images of the isolated tumors from the injected mice (n = 10, **P < 0.01)

Back to article page